|Titre :||An evaluation of the Government's Drug Strategy 2010|
|Auteurs :||HM Government ; Home Office|
|Type de document :||Rapport|
|Editeur :||London : Home Office, 2017|
|Format :||220 p.|
|Discipline :||SAN (Santé publique / Public health)|
Thésaurus TOXIBASELUTTE ; PLANIFICATION SANITAIRE ; EVALUATION ; INTERVENTION ; EPIDEMIOLOGIE ; MEDIA ; TRAITEMENT ; EFFICACITE ; DEPENSES DE SANTE
The evaluation of the Government's Drug Strategy 2010 contributes greatly to the evidence base for the Government's new Drug Strategy. As such, this evaluation covers the strategy to the end of 2015 to provide sufficient time to feed into the development of the new strategy.
However, a few 2016 and 2017 reports are also included for completeness.
The evaluation focusses on activities carried out in England only, and includes those activities that contribute to the aims of the strategy and receive, at least in some part, central government funding.
In the absence of the data and high quality evidence necessary to undertake a full impact evaluation of the strategy, the evaluation is based on a theory of change approach, following the stages below:
- identifying the types of activity that fall within the strategy;
- describing how the activities theoretically contribute to the aims of the strategy (using logic models);
- assessing the effectiveness of the activities, and where possible, value for money, using the best available evidence; and
- producing estimates of government spend on specified activities.
The Government made it clear that it would not be desirable or achievable to undertake a single evaluation encompassing the whole of the strategy, nor to provide a single value for money estimate (HM Government, 2013). Instead relevant programmes and interventions have been divided into five activity groups that incorporate the strategy's three themes.
1. Early interventions (reducing demand).
2. Media and information approaches (reducing demand).
3. Enforcement and enforcement-related activity (restricting supply / building recovery).
4. Treatment (building recovery / reducing demand).
5. Non-treatment rehabilitative activity (building recovery / reducing demand).
Assessing these five components separately however, does not fully take into account the effectiveness of the strategy as a whole. It is recognised that all three themes, under which the activity groups sit, are important to build recovery and tackle drug-related harms and that each in isolation is likely to be less effective than the combined impact.
|Domaine :||Plusieurs produits / Several products|
|Titre précédent :|
Documents numériques (1)
Adobe Acrobat PDF